SCHEMBL3956271

SCHEMBL3956271

CCCCSc1nc(N)c2ncn(Cc3ccc(Cl)cc3F)c2n1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 2/20 0.42
PDE8A O60658 1/20 0.42
ADORA3 P0DMS8 1/20 0.40
HDAC3 O15379 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC7 Q8WUI4 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC10 Q969S8 1/20 0.39
HDAC11 Q96DB2 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC9 Q9UKV0 1/20 0.39
HDAC5 Q9UQL6 1/20 0.39
TP53 P04637 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
HIF1A Q16665 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3958861 0.93 PDE8A (0.43) PDE8AADORA3
SCHEMBL3956364 0.90 ADORA3 (0.43) HDAC6ADORA3
SCHEMBL3952557 0.89 HDAC6 (0.40) HDAC6ADORA3
SCHEMBL3958684 0.88 PDE8A (0.43) PDE8AADORA3TP53CYP1A2CYP3A4
SCHEMBL3954593 0.86 CNR2 (0.43) ADORA3
SCHEMBL3954981 0.86 ADORA3 (0.43) ADORA3
SCHEMBL3961113 0.86 PDE4A (0.49)
SCHEMBL3959850 0.85 PDE4A (0.43) HDAC6PDE8AADORA3HDAC3HDAC4
SCHEMBL3955318 0.85 ADORA3 (0.42) ADORA3
SCHEMBL30464118 0.83 ADORA3 (0.41) ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009034386-A1 DERIVATIVES OF ADENINE AND 8-AZA-ADENINE AND USES THEREOF-796 ASTRAZENECA AB (SE) 2009-03-19 WO claimed
WO-2009034386-A1 DERIVATIVES OF ADENINE AND 8-AZA-ADENINE AND USES THEREOF-796 ASTRAZENECA AB (SE) 2009-03-19 WO disclosed